Comparative study of anti-VEGF Ranibizumab and Interleukin-6 receptor antagonist Tocilizumab in Adjuvant-induced Arthritis

2018 ◽  
Vol 356 ◽  
pp. 65-75 ◽  
Author(s):  
Amany El-Shahawy Abdel-Maged ◽  
Amany M. Gad ◽  
Amal Kamal Abdel-Aziz ◽  
Mohammad M. Aboulwafa ◽  
Samar S. Azab
Keyword(s):  
Comparative Study ◽  
Receptor Antagonist ◽  
Interleukin 6 ◽  
Adjuvant Induced Arthritis ◽  
Anti Vegf ◽  
Interleukin 6 Receptor

The effect of tocilizumab - an interleukin-6 receptor antagonist - on lipid levels in rheumatoid arthritis

2017 ◽  
Author(s):  
Ifigenia Kostoglou-Athanassiou ◽  
Lambros Athanassiou ◽  
Aikaterini Tzanavari ◽  
Charoula Katsavouni ◽  
Markos Kostopoulos ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Receptor Antagonist ◽  
Interleukin 6 ◽  
Lipid Levels ◽  
Interleukin 6 Receptor

scholarly journals Severe COVID ‐19 and interleukin‐6 receptor antagonist tocilizumab: Some notes of concern

Respirology ◽  
2020 ◽  
Vol 25 (11) ◽  
pp. 1209-1209 ◽  
Author(s):  
Karolina Akinosoglou ◽  
Charalambos Gogos
Keyword(s):  
Receptor Antagonist ◽  
Interleukin 6 ◽  
Interleukin 6 Receptor

scholarly journals Development of a human interleukin-6 receptor antagonist.

1994 ◽  
Vol 269 (1) ◽  
pp. 86-93 ◽  
Author(s):  
J.P. Brakenhoff ◽  
F.D. de Hon ◽  
V. Fontaine ◽  
E. ten Boekel ◽  
H. Schooltink ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Interleukin 6 ◽  
Interleukin 6 Receptor
Sign in / Sign up

Export Citation Format

Share Document